Legal & General Group PLC Aldeyra Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $390 Billion
  • Q2 2025

A detailed history of Legal & General Group PLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 5,836 shares of ALDX stock, worth $28,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,836
Previous 4,397 32.73%
Holding current value
$28,596
Previous $25,000 12.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$1.42 - $5.48 $2,043 - $7,885
1,439 Added 32.73%
5,836 $22,000
Q3 2024

Nov 14, 2024
BUY
$3.19 - $6.32 $893 - $1,769
280 Added 6.8%
4,397 $23,000
Q2 2024

May 29, 2025
SELL
$3.25 - $4.72 $3,282 - $4,767
-1,010 Reduced 19.7%
4,117 $13,000
Q2 2024

Aug 14, 2024
SELL
$3.25 - $4.72 $3,282 - $4,767
-1,010 Reduced 19.7%
4,117 $13,000
Q1 2024

May 29, 2025
BUY
$2.77 - $4.22 $2,022 - $3,080
730 Added 16.6%
5,127 $16,000
Q1 2024

May 14, 2024
SELL
$2.77 - $4.22 $11,670 - $17,778
-4,213 Reduced 45.11%
5,127 $16,000
Q4 2023

May 29, 2025
BUY
$1.47 - $6.06 $7,266 - $29,954
4,943 Added 112.42%
9,340 $32,000
Q4 2023

Feb 15, 2024
SELL
$1.47 - $6.06 $41,533 - $171,219
-28,254 Reduced 75.16%
9,340 $32,000
Q3 2023

Nov 14, 2023
SELL
$6.11 - $8.16 $1,851 - $2,472
-303 Reduced 0.8%
37,594 $251,000
Q2 2023

Aug 14, 2023
BUY
$7.11 - $11.89 $269,447 - $450,595
37,897 New
37,897 $317,000
Q2 2022

Aug 22, 2022
SELL
$2.43 - $4.85 $12,852 - $25,651
-5,289 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.25 - $5.17 $997 - $1,587
307 Added 6.16%
5,289 $24,000
Q4 2021

Feb 14, 2022
SELL
$3.5 - $9.63 $525 - $1,444
-150 Reduced 2.92%
4,982 $20,000
Q2 2021

Aug 12, 2021
BUY
$10.44 - $14.85 $53,578 - $76,210
5,132 New
5,132 $58,000
Q2 2020

Aug 14, 2020
SELL
$1.97 - $5.05 $7,690 - $19,715
-3,904 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$4.73 - $7.98 $2,942 - $4,963
622 Added 18.95%
3,904 $23,000
Q4 2018

Feb 15, 2019
BUY
$7.26 - $13.29 $6,693 - $12,253
922 Added 39.07%
3,282 $27,000
Q2 2018

Aug 10, 2018
BUY
$6.95 - $9.18 $16,402 - $21,664
2,360 New
2,360 $19,000

Others Institutions Holding ALDX

# of Institutions
134
Shares Held
34.9M
Call Options Held
244K
Put Options Held
51.6K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $286M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email